ESTHER MCCORKINDALE: Open Payments
NPI 1023005543 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 12 payments from 10 companies in 2025. Trend: 2023 $627 · 2024 $613 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $49 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $48 |
| IMMUNITYBIO, INC. | 2 | $41 |
| Janssen Biotech, Inc. | 1 | $31 |
| Endo USA, Inc. | 1 | $28 |
| Calyxo, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $21 |
| Boston Scientific Corporation | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| 180 Medical, Inc. | 1 | $15 |
Products named: GEMTESA, Bard Urinary Drainage Bag, ANKTIVA, ERLEADA, AVEED, CVAC ASPIRATION SYSTEM, iTIND System, Obtryx System - Curved.
Industry payments across WA — which companies pay providers there.
